These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 14702004)
1. Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. Grossman H CNS Spectr; 2003 Nov; 8(11):815-23. PubMed ID: 14702004 [TBL] [Abstract][Full Text] [Related]
2. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort. Chambers A; Bury JJ; Minett T; Richardson CD; Brayne C; Ince PG; Shaw PJ; Garwood CJ; Heath PR; Simpson JE; Matthews FE; Wharton SB J Neuropathol Exp Neurol; 2020 Sep; 79(9):950-958. PubMed ID: 32766675 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. Beeri MS; Silverman JM; Davis KL; Marin D; Grossman HZ; Schmeidler J; Purohit DP; Perl DP; Davidson M; Mohs RC; Haroutunian V J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):471-5. PubMed ID: 15933386 [TBL] [Abstract][Full Text] [Related]
5. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
7. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Muramori F; Kobayashi K; Nakamura I Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians. Giannakopoulos P; Hof PR; Vallet PG; Giannakopoulos AS; Charnay Y; Bouras C Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):577-92. PubMed ID: 8588057 [TBL] [Abstract][Full Text] [Related]
9. [Is there sugar in the Alzheimer's disease?]. Frey J Ann Biol Clin (Paris); 2001; 59(3):253-7. PubMed ID: 11397672 [TBL] [Abstract][Full Text] [Related]
12. Comparison between Alzheimer's disease and vascular dementia: implications for treatment. Kalaria RN Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021 [TBL] [Abstract][Full Text] [Related]
13. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Yilmazer-Hanke DM; Hanke J Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378 [TBL] [Abstract][Full Text] [Related]
14. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease. Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654 [TBL] [Abstract][Full Text] [Related]
15. G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies. García-Jiménez A; Fastbom J; Ohm TG; Cowburn RF Neuroreport; 2003 Aug; 14(11):1523-7. PubMed ID: 12960778 [TBL] [Abstract][Full Text] [Related]
16. The challenge of characterizing normal brain aging in relation to Alzheimer's disease. Morris JC Neurobiol Aging; 1997; 18(4):388-9; discussion 389-92. PubMed ID: 9330969 [No Abstract] [Full Text] [Related]
17. Alzheimer's disease as a disconnection syndrome? Delbeuck X; Van der Linden M; Collette F Neuropsychol Rev; 2003 Jun; 13(2):79-92. PubMed ID: 12887040 [TBL] [Abstract][Full Text] [Related]